ING Groep NV Sells 23,069 Shares of The Cooper Companies, Inc. $COO

ING Groep NV lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 89.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,723 shares of the medical device company’s stock after selling 23,069 shares during the period. ING Groep NV’s holdings in Cooper Companies were worth $223,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. New York Life Investment Management LLC lifted its stake in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after acquiring an additional 158 shares during the last quarter. Root Financial Partners LLC grew its position in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. Allworth Financial LP increased its holdings in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after purchasing an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. increased its holdings in Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after purchasing an additional 175 shares in the last quarter. Finally, Blue Trust Inc. raised its position in Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after purchasing an additional 185 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Key Stories Impacting Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Recent commentary highlighted The Cooper Companies as a strong long-term growth name, with Zacks calling it a top growth stock and Seeking Alpha noting potential for an analyst upgrade as valuation improves. Article Title
• Positive Sentiment: Analysts and market commentary also pointed to the company’s demand growth and prior quarterly earnings beat, which can reinforce confidence in revenue momentum. Article Title
• Neutral Sentiment: One article noted that Cooper has strong revenue growth, especially in CooperVision, but also said litigation charges tied to embryo culture media recalls have weighed on reported profitability; these issues do not appear to change the long-term outlook materially. Article Title
• Negative Sentiment: Some analysis still argues The Cooper Companies needs stronger return on equity and profit margins, which may temper enthusiasm despite solid sales trends. Article Title

Analyst Upgrades and Downgrades

A number of analysts have recently commented on COO shares. Mizuho set a $85.00 price target on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Needham & Company LLC reduced their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research report on Wednesday, May 27th. Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Finally, Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $82.64.

Cooper Companies Price Performance

Cooper Companies stock opened at $67.69 on Thursday. The stock’s 50 day moving average is $64.94 and its 200 day moving average is $74.45. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The firm has a market cap of $13.20 billion, a P/E ratio of 57.36, a P/E/G ratio of 1.80 and a beta of 0.87. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the prior year, the business posted $0.96 earnings per share. The firm’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.